Protect Animal Health and DotBio Join Forces to Develop Therapies and Technologies for Companion Animals
Shots:
- Protect Animal Health (PAH) & DotBio have entered into a strategic partnership for developing an antibody discovery platform & new therapeutic antibody portfolio to improve the quality of life in companion animals, specifically, dogs & cats
- The partnership will employ DotBio’s DotBodies platform & intracellular antibody technology for developing therapeutic antibodies addressing diseases in canine & feline populations
- Both will further identify & optimize high-affinity, multi-specific antibodies, for treating autoimmune diseases, cancers & chronic inflammatory disorders
Ref: Protect Animal Health and DotBio | Image: Protect Animal Health and DotBio
Related News:- Merck Animal Health’s Innovax-ND-H5 Vaccine Gains the EC’s Marketing Authorization for Chickens
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
